PCM
HOOK

Prelude Capital Management’s HOOKIPA Pharma HOOK Stock Holding History

Prelude Capital Management’s Portfolio HOOK Stock Details HOOK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-39
Closed -$4K – 1570
2020
Q3 		$4K Buy
39
+20
+105% +$2.04K ﹤0.01% 1589
2020
Q2 		$2K Hold
19
– – ﹤0.01% 1825
2020
Q1 		$2K Sell
19
-245
-93% -$26.8K ﹤0.01% 1311
2019
Q4 		$32K Buy
264
+231
+700% +$19.6K ﹤0.01% 1481
2019
Q3 		$2K Buy
+33
New +$2.44K ﹤0.01% 1620

Other funds holding HOOK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Prelude Capital Management's HOOK Position: Q4 2020 in Review

Prelude Capital Management sold out of HOOKIPA Pharma (HOOK) in Q4 2020, closing a stake of 39 shares — an estimated $4K sold.

Prelude Capital Management first reported a position in HOOK in Q3 2019 and held it in 5 quarters. The position peaked at $32K in Q4 2019. 53 funds tracked by Wall St. Rank hold HOOK as of Q4 2020.

  • Prelude Capital Management reported no remaining HOOKIPA Pharma position as of Q4 2020 after selling out during the quarter.
  • Prelude Capital Management sold 39 HOOKIPA Pharma shares in Q4 2020, an estimated $4K.
  • Prelude Capital Management first reported a position in HOOKIPA Pharma in Q3 2019 and held it in 5 quarters.
  • Prelude Capital Management's HOOKIPA Pharma position peaked at $32K in Q4 2019.
  • 53 funds tracked by Wall St. Rank held HOOKIPA Pharma as of Q4 2020.

Based on Prelude Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.